Je was op zoek naar: intramuskularni (Sloveens - Engels)

angiox ni namenjen intramuskularni uporabi.
angiox is not intended for intramuscular use.

ne aplicirajte po intravenski ali intramuskularni poti.
do not administer by the intravenous or intramuscular route.

zdravilo trevicta je namenjeno samo intramuskularni uporabi.
trevicta is intended for intramuscular use only.

odzivi po intramuskularni in subkutani uporabi se popolnoma prekrivajo.
intramuscular and subcutaneous administrations produce fully superimposable responses.

podobni so si tudi presnovni profili po intramuskularni in peroralni uporabi.
the metabolic profiles following intramuscular and oral use are similar.

absorpcija po peroralni in intramuskularni uporabi kaže na dobro biološko razpoložljivost.
absorption after oral and intramuscular administration shows a high bioavailability.

izpostavljenost interferonu beta je ekvivalentna po subkutani ali intramuskularni uporabi zdravila rebif.
subcutaneous and intramuscular administrations of rebif produce equivalent exposure to interferon beta.

zaradi tveganja za lokalni hematom se desirudin ne sme aplicirati v intramuskularni injekciji.
desirudin should not be administered by intramuscular injection owing to the risk of local haematoma.

izpostavljenost valdekoksibu je bila glede na auc in cmaks po intravenski in intramuskularni uporabi podobna.
exposure to valdecoxib was similar in terms of auc and cmax following iv and im administration.

ne sme se dajati po nobeni drugi poti, na primer intratekalni, intramuskularni ali subkutani.
it must not be given by other routes of administration, such as the intrathecal, intramuscular, or subcutaneous route.

kot pri peroralni uporabi sta cmax in površina pod krivuljo po intramuskularni uporabi neposredno sorazmerna danemu odmerku.
as with oral use, cmax and area under the curve after intramuscular use are directly proportional to the dose administered.

tako pri subkutani uporabi kot pri intramuskularni uporabi je bila biološka uporabnost zdravila večja od 100 %.
both subcutaneous and intramuscular administration resulted in bioavailabilities greater than 100 %.

po intravenski ali intramuskularni injekciji se parekoksib z encimsko hidrolizo v jetrih hitro spremeni v farmakološko aktivno učinkovino valdekoksib.
following iv or im injection, parecoxib is rapidly converted to valdecoxib, the pharmacologically active substance, by enzymatic hydrolysis in the liver.

puregon dajte bolniku v počasni intramuskularni ali subkutani injekciji, da preprečite bolečino in zmanjšate iztekanje na mestu injiciranja.
to prevent painful injections and minimise leakage from the injection site puregon should be slowly administered intramuscularly or subcutaneously.

otrokom s trombocitopenijo ali motnjami strjevanja krvi cepivo infanrix hexa dajemo previdno, ker se pri njih po intramuskularni aplikaciji lahko pojavi krvavitev.
infanrix hexa should be administered with caution to subjects with thrombocytopenia or a bleeding disorder since bleeding may occur following an intramuscular administration to these subjects.

do cmax pride prej po intramuskularni uporabi kot po peroralni uporabi (15 do 45 minut v primerjavi s 5 do 8 ur).
the cmax occurs earlier after intramuscular compared to oral use (15 to 45 minutes versus 5 to 8 hours).

enotedensko uvajalno odmerjanje (intramuskularni injekciji ob dnevih 1 in 8), kot je opisano v poglavju 4.2, ni potrebno.
the one-week initiation dosing regimen including the intramuscular injections (day 1 and 8, respectively) as described in section 4.2 above is not required.

intravenski odmerek je 375 mikrogramov/ kvadratni meter telesne površine, intramuskularni odmerek pa je 500 mikrogramov/ kvadratni meter telesne površine, kadar je deksmedetomidin uporabljen kot edina učinkovina za sedacijo in analgezijo.
the intravenous dose is 375 micrograms/ square metre body surface area and the intramuscular dose is 500 micrograms/ square metre body surface area when dexmedetomidine is used as the only agent for sedation and analgesia.

pri skupni uporabi z butorfanolom (0,1 mg/kg) za globoko sedacijo in analgezijo je intramuskularni odmerek deksmedetomidina 300 mikrogramov/kvadratni meter telesne površine.
when administering in conjunction with butorphanol (0.1 mg/kg) for deep sedation and analgesia, the intramuscular dose of dexmedetomidine is 300 micrograms/square metre body surface area.